SUBSCRIBE
SUBSCRIBE
News   FDA

ZymoGenetics, Inc. Drug Gets Canadian Approval

December 16, 2009 | 
1 min read

Bookmark and Share

ZymoGenetics, the Seattle-based biotech company, said today in a regulatory filing that its drug to control excess surgical bleeding has received approval from Canadian regulators.

FDA Approvals
MORE ON THIS TOPIC
Poster. Contemporary art collage. Blue and yellow hands peeking out of black holes in space to make a deal. Abstract vibrant artwork. Concept of pop art, positive emotions. Minimal art design.
Cancer
Kura Signs Leukemia Pact with Kyowa Kirin After Losing Race to Syndax
November 21, 2024
 · 
2 min read
 · 
Tristan Manalac
Marty Makary speaks on a panel at the New America Foundation
Government
COVID-19 Critic Marty Makary Is Trump’s Likely Pick for FDA Top Post
November 21, 2024
 · 
2 min read
 · 
Tristan Manalac
Robert F. Kennedy Jr.
Government
Trump Picks RFK Jr. to Lead HHS
November 15, 2024
 · 
3 min read
 · 
Tristan Manalac
FDA signage at its headquarters in Maryland
Approvals
PTC Wins First FDA Nod for Direct-to-Brain Gene Therapy, Targets Ultrarare Disease
November 14, 2024
 · 
2 min read
 · 
Tristan Manalac